Dembek, Carole; White, Leigh; Quach, Jayson; Szkurhan, … - In: The European Journal of Health Economics 15 (2014) 4, pp. 353-362
In our cost-effectiveness analysis of first-line injectable DMTs in Spain, we found IM IFNβ-1a to be more cost-effective than SC IFNβ-1a, IFNβ-1b or GA. Sensitivity analyses confirmed the robustness of these results. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014